Large-scale, high-throughput production of rSIV.F/HN vectors

Documents similaires

• Rapid determination of rSIV.F/HN lentiviral vector titre
  par: Conway, CC, et autres
  Publié: (2020)
• Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
  par: Gamlen, T, et autres
  Publié: (2020)
• Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
  par: Sergijenko, A, et autres
  Publié: (2021)
• Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
  par: Pytel, K, et autres
  Publié: (2016)
• Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
  par: Hyde, S, et autres
  Publié: (2015)